Document Detail


The upcoming field of theranostic nanomedicine: an overview.
MedLine Citation:
PMID:  23029995     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Nanocarriers have drastically changed the face of health care by making a mark in diverse arenas of diagnosis, drug delivery, and gene delivery to name a few. The recent feat in nanotechnology has been the birth of nanotheranostics which aims at blending both therapeutic and diagnostic functions within a single nanoscaffold. The field of theranostic nanomedicine is a result of fruitful advances in fields of material science, imaging modalities, formulation development, and molecular biology. Theranostic nanomedicine that was at first developed for enhancing the quality of treatment meted out to cancer patients has now been explored even in atherosclerosis and infections, albeit to a lower extent. The review summarizes various types of nanocarriers that have been explored with one or sometimes multiple imaging modalities for an array of applications ranging from drug delivery and gene delivery to photosensitizing agent delivery for photodynamic therapy. The article also highlights the few but significant developments made in the field of theranostic nanomedicine for atherosclerosis and infections. In conclusion, theranostic nanomedicine is a rapidly growing field. However, there are a few problems that need to be addressed before theranostic nanocarriers carve a niche for themselves in the clinic.
Authors:
Priyanka Prabhu; Vandana Patravale
Related Documents :
23731975 - Phenotypes of intermediate forms of fasciola hepatica and f. gigantica in buffaloes fro...
23639215 - Detection experiments with humans implicate visual predation as a driver of colour poly...
22912625 - Unmasking the perky effect: spatial extent of image interference on visual acuity.
24044715 - Acute exudative polymorphous vitelliform maculopathy in a patient with lyme disease.
20617435 - Molecular imaging of angiogenesis with spect.
21076685 - Fast numerical solutions of patient-specific blood flows in 3d arterial systems.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of biomedical nanotechnology     Volume:  8     ISSN:  1550-7033     ISO Abbreviation:  J Biomed Nanotechnol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-10-03     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230869     Medline TA:  J Biomed Nanotechnol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  859-82     Citation Subset:  IM    
Affiliation:
Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Matunga, Mumbai 400019, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  [Management of arterial hypertension in Tunisia: the challenge of a developing country].
Next Document:  Local field enhanced Au/CuS nanocomposites as efficient photothermal transducer agents for cancer tr...